Ali Najafyar

Molecular engineering and clinical translation of T cell engaging bispecific antibodies in cancer therapy

Abstract Bispecific T-cell engagers are Fc-less, Fv-based members of the broader family of T-cell-engaging bispecific antibodies designed to redirect cytotoxic T cells toward tumor cells by simultaneously binding CD3 and tumor-associated antigens. Despite their clinical promise,...